IP Library › Assignment 049041/0530
Patent Assignment
Reel/Frame 049041/0530

Change of Name

Recorded: 2019-04-30 Pages: 6
Assignor
NOVELIX PHARMACEUTICALS, INC.
Executed: 2018-01-17
Assignee
DERM-BIOME INC.
8 THE GREEN, SUITE A, DOVER, DELAWARE, 19901
Covered Properties (4)
Compositions and Methods for Treatment of Infection and Novel Cosmeceutical Preparations
Methods and Compositions for Inhibiting Tumor Growth
Patent: 7,312,205 →
Application: 10/545,143 →
Publication: US 2006/0194774
Methods and Compositions for Inhibiting Tumor Growth
Patent: 7,851,462 →
Application: 11/963,505 →
Publication: US 2008/0214516
Novel (Pyrroloquinoxalinyl) Pyrazinecarbohydrazide-Oxalic Acid Co-Crystal for Treatment of Cancer and Other Diseases
Patent: 8,058,437 →
Application: 12/937,245 →
Publication: US 2011/0034473
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 13, 2006
From: JANSEN, BURKHARD; PASCHKE, REINHARD; SELZER, EDGAR
To: NOVELIX PHARMACEUTICALS, INC.
Reel/Frame 018512/0469 →
Assignment of Assignor's Interest Apr 30, 2019
From: DERM-BIOME INC.
To: DERM-BIOME PHARMACEUTICALS INC.
Reel/Frame 049035/0279 →